The store will not work correctly when cookies are disabled.
5-tert-Butyl-6-chloro-N-(3-trifluoromethylphenyl)pyrazine-2-carboxamide
ID: ALA496157
PubChem CID: 24863349
Max Phase: Preclinical
Molecular Formula: C16H15ClF3N3O
Molecular Weight: 357.76
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ncc(C(=O)Nc2cccc(C(F)(F)F)c2)nc1Cl
Standard InChI: InChI=1S/C16H15ClF3N3O/c1-15(2,3)12-13(17)23-11(8-21-12)14(24)22-10-6-4-5-9(7-10)16(18,19)20/h4-8H,1-3H3,(H,22,24)
Standard InChI Key: OITRXFQJXBGAQQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
-3.1306 0.8959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1318 0.0685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4169 -0.3444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7005 0.0690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7034 0.8995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4187 1.3086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9904 1.3147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2744 0.9049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9936 2.1397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4385 1.3201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1529 0.9068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8653 1.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8627 2.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1416 2.5568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4322 2.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8465 -0.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5667 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4378 -1.0600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2536 0.3742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8452 1.3082 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5812 0.9112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 0.5000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.9929 1.6261 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1730 0.1942 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
2 16 1 0
7 8 1 0
16 17 1 0
16 18 1 0
7 9 2 0
16 19 1 0
4 5 1 0
1 20 1 0
8 10 1 0
12 21 1 0
2 3 1 0
21 22 1 0
10 11 2 0
21 23 1 0
5 6 2 0
21 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 357.76 | Molecular Weight (Monoisotopic): 357.0856 | AlogP: 4.70 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.62 | CX Basic pKa: ┄ | CX LogP: 4.65 | CX LogD: 4.65 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -1.83 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |